Erin D. Michos, M.D.(@ErinMichos) 's Twitter Profileg
Erin D. Michos, M.D.

@ErinMichos

Johns Hopkins Medicine. Associate Professor, Cardiology. Co-Editor in Chief @AJPCardio. #WomenHeartHealth #CardioObstetrics #cvPrev #echofirst She/her #BeKind

ID:2934375069

linkhttp://www.hopkinsmedicine.org/profiles/results/directory/profile/0015713/erin-michos calendar_today20-12-2014 23:42:12

32,6K Tweets

26,5K Followers

9,6K Following

Salman Zahid(@SalmanZahidMD) 's Twitter Profile Photo

Thank you Erin D. Michos, M.D. for grooming me for this success. I would not have imagined myself in this position a year ago if it was not for your mentorship. It’s a privilege to have made these contributions to CardioObs under your wings!

account_circle
Chris “The Chiu Man' Chiu, MD(@cjchiu) 's Twitter Profile Photo

I had such a great time making this episode. Huge thanks to Erin D. Michos, M.D. for reaching our 'guest second-timers' club. If you get your card stamped on the next one, you'll get a free caffeinated beverage. Special thanks to Ohio State Internal Medicine Residency Dr. Jimmy Antaki for the show notes!

account_circle
Taher Modarressi, M.D.(@tmodarressi) 's Twitter Profile Photo

Patients often have significant and reasonable concerns about pill burden and copays. Here's a quick 🧵 about combo oral diabetes medications I use:

Patients often have significant and reasonable concerns about pill burden and copays. Here's a quick 🧵 about combo oral diabetes medications I use:
account_circle
Vindico Medical Education(@VindicoMedEd) 's Twitter Profile Photo

Stay up to date on the latest clinical data on obesity and the impact of weight loss on CV risk in women with this newly posted activity: ow.ly/HNBF50LeJlN @drmarthagulati Erin D. Michos, M.D. Pam R. Taub, MD

Stay up to date on the latest clinical data on obesity and the impact of weight loss on CV risk in women with this newly posted #CME activity: ow.ly/HNBF50LeJlN @drmarthagulati @ErinMichos @PamTaubMD
account_circle
Christie Ballantyne(@CBallantyneMD) 's Twitter Profile Photo

Excellent summary of session covering how to assess risk in primary prevention Michael J. Blaha , residual risk post statin in secondary prevention Erin D. Michos, M.D. and where and when to use new therapies Pam R. Taub, MD

account_circle